{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T20:27:47Z","timestamp":1785875267213,"version":"3.56.0"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2006,2,1]],"date-time":"2006-02-01T00:00:00Z","timestamp":1138752000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Thromb Thrombolysis"],"published-print":{"date-parts":[[2006,2]]},"DOI":"10.1007\/s11239-006-5579-4","type":"journal-article","created":{"date-parts":[[2006,2,11]],"date-time":"2006-02-11T10:47:23Z","timestamp":1139654843000},"page":"67-72","source":"Crossref","is-referenced-by-count":75,"title":["New Anticoagulants: Anti IIa vs Anti Xa\u2014Is One Better?"],"prefix":"10.1007","volume":"21","author":[{"given":"Kenneth A.","family":"Bauer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"5579_CR1","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1056\/NEJMoa035162","volume":"349","author":"CW Francis","year":"2003","unstructured":"Francis CW, Berkowitz SD, Comp PC, et al. Comparison of ximelagatran and warfarin for the prevention of venous thromboembolism after total knee replacement. N Engl J Med 2003;349:1703\u20131712.","journal-title":"N Engl J Med"},{"key":"5579_CR2","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.2106\/00004623-200510000-00003","volume":"87","author":"CW Colwell","year":"2005","unstructured":"Colwell CW, Berkowitz SD, Lieberman JR, et al. Oral direct thrombin inhibitor ximelagatran compared with warfarin for the prevention of venous thromboembolism after total knee arthroplasty. J Bone Joint Surg Am 2005;87:2169\u20132177.","journal-title":"J Bone Joint Surg Am"},{"key":"5579_CR3","doi-asserted-by":"crossref","unstructured":"Feissinger J-N, Huisman MV, Davidson BL, et al for the THRIVE Treatment Study Investigators. Ximelagatran vs low-molecular-weight heparin and warfarin for the treatment of deep vein thrombosis: a randomized trial. JAMA 2005;293:681\u2013689.","DOI":"10.1001\/jama.293.6.681"},{"key":"5579_CR4","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1056\/NEJMoa030104","volume":"349","author":"S Schulman","year":"2003","unstructured":"Schulman S, W\u00e4hlander K, Lundstr\u00f6m, et al. Secondary prevention of venous thromboembolism with the oral direct thrombin inhibitor ximelagatran. N Engl J Med 2003;349:1713\u20131721.","journal-title":"N Engl J Med"},{"issue":"Suppl","key":"5579_CR5","doi-asserted-by":"crossref","first-page":"265S","DOI":"10.1378\/chest.126.3_suppl.265S","volume":"126","author":"JI Weitz","year":"2004","unstructured":"Weitz JI, Hirsh J, Samama MM. New anticoagulant drugs. The Seventh ACCP Conference on antithrombotic and thrombolytic therapy. Chest 2004;126(Suppl):265S\u2013286S.","journal-title":"Chest"},{"issue":"Suppl","key":"5579_CR6","first-page":"30","volume":"350","author":"M Petitou","year":"1991","unstructured":"Petitou M, Lormeau JC, Choay J. Chemical synthesis of glycosaminoglycans: new approaches to antithrombotic drugs. Nature. 1991;350(Suppl):30\u201333.","journal-title":"Nature"},{"key":"5579_CR7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1527-3466.1997.tb00321.x","volume":"15","author":"JM Herbert","year":"1997","unstructured":"Herbert JM, Petitou M, Lormeau JC, et al. SR 90107\/Org 31540, a novel anti-factor Xa antithrombotic agent. Cardiovasc Drug Rev 1997;15:1\u201326.","journal-title":"Cardiovasc Drug Rev"},{"key":"5579_CR8","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1016\/S0140-6736(02)08652-X","volume":"359","author":"MR Lassen","year":"2002","unstructured":"Lassen MR, Bauer KA, Eriksson BI, et al. Postoperative fondaparinux versus preoperative enoxaparin for prevention of venous thromboembolism in elective hip-replacement surgery: a randomised double-blind comparison. Lancet. 2002;359:1715\u20131720.","journal-title":"Lancet"},{"key":"5579_CR9","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1016\/S0140-6736(02)08648-8","volume":"359","author":"AGG Turpie","year":"2002","unstructured":"Turpie AGG, Bauer KA, Eriksson BI, et al. Postoperative fondaparinux versus postoperative enoxaparin for prevention of venous thromboembolism after elective hip-replacement surgery: a randomised double-blind trial. Lancet 2002;359:1721\u20131726.","journal-title":"Lancet"},{"key":"5579_CR10","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1056\/NEJMoa011099","volume":"345","author":"KA Bauer","year":"2001","unstructured":"Bauer KA, Eriksson BI, Lassen MR, et al: Fondaparinux compared with enoxaparin for the prevention of venous thromboembolism after elective major knee surgery. N Engl J Med 2001;345:1305\u20131310.","journal-title":"N Engl J Med"},{"key":"5579_CR11","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1056\/NEJMoa011100","volume":"345","author":"BI Eriksson","year":"2001","unstructured":"Eriksson BI, Bauer KA, Lassen MR, et al: Fondaparinux compared with enoxaparin for the prevention of venous thromboembolism after hip-fracture surgery. N Engl J Med. 2001;345:1298\u20131304.","journal-title":"N Engl J Med."},{"key":"5579_CR12","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1001\/archinte.162.16.1833","volume":"162","author":"AGG Turpie","year":"2002","unstructured":"Turpie AGG, Bauer KA, Eriksson BI, et al. Fondaparinux versus enoxaparin for the prevention of venous thromboembolism in major orthopedic surgery. A meta-analysis of 4 randomized studies. Arch Intern Med 2002;162;1833\u20131840.","journal-title":"Arch Intern Med"},{"key":"5579_CR13","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1001\/archinte.163.11.1337","volume":"163","author":"BI Eriksson","year":"2003","unstructured":"Eriksson BI, Lassen MR. Duration of Prophylaxis against thromboembolism with fondaparinux after hip fracture surgery: A mulicenter, randomized, placebo-controlled, double-blind study. Arch Intern Med 2003;163:1337\u20131342.","journal-title":"Arch Intern Med"},{"key":"5579_CR14","doi-asserted-by":"crossref","unstructured":"Agnelli G, Bergqvist D, Cohen AT, et al., on behalf of the PEGASUS investigators. Randomized clinical trial of postoperative fondaparinux versus perioperative dalteparin for prevention of venous thromboembolism in high-risk abdominal surgery. Br J Surgery 2005;92:1212\u20131226.","DOI":"10.1002\/bjs.5154"},{"key":"5579_CR15","doi-asserted-by":"crossref","first-page":"867","DOI":"10.7326\/0003-4819-140-11-200406010-00007","volume":"140","author":"HR Buller","year":"2004","unstructured":"Buller HR, Davidson BL, Decousus H, et al. Fondaparinux or enoxaparin for the initial treatment of symptomatic deep venous thrombosis: a randomized trial. Ann Intern Med 2004;140:867\u2013873.","journal-title":"Ann Intern Med"},{"key":"5579_CR16","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1056\/NEJMoa035451","volume":"349","author":"The Matisse Investigators","year":"2003","unstructured":"The Matisse Investigators. Subcutaneous fondaparinux versus intravenous unfractionated heparin in the initial treatment of pulmonary embolism. N Engl J Med. 2003;349:1695\u20131702.","journal-title":"N Engl J Med."}],"container-title":["Journal of Thrombosis and Thrombolysis"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11239-006-5579-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11239-006-5579-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11239-006-5579-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T07:01:31Z","timestamp":1559372491000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11239-006-5579-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,2]]},"references-count":16,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2006,2]]}},"alternative-id":["5579"],"URL":"https:\/\/doi.org\/10.1007\/s11239-006-5579-4","relation":{},"ISSN":["0929-5305","1573-742X"],"issn-type":[{"value":"0929-5305","type":"print"},{"value":"1573-742X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,2]]}}}